These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3178598)

  • 1. Malignant hyperthermia and the conscious patient.
    Kemp DR; Choong LS
    Aust N Z J Surg; 1988 May; 58(5):423-7. PubMed ID: 3178598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
    Friesen CM; Brodsky JB; Dillingham MF
    Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
    Harrison GG
    S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia in a young adolescent: A case report.
    Toh H; Shahani JM; Ali AJ
    Natl Med J India; 2014; 27(5):259-60. PubMed ID: 26037425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia following preoperative oral administration of dantrolene.
    Fitzgibbons DC
    Anesthesiology; 1981 Jan; 54(1):73-5. PubMed ID: 7457985
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant hyperthermia in the ambulatory surgery center: how should we prepare?
    Litman RS; Joshi GP
    Anesthesiology; 2014 Jun; 120(6):1306-8. PubMed ID: 24710219
    [No Abstract]   [Full Text] [Related]  

  • 7. Dantrium: the approved drug to control malignant hyperthermia.
    Gever LN
    Nursing; 1980 Jul; 10(7):62. PubMed ID: 6900937
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
    Harrison GG
    Br J Anaesth; 1975 Jan; 47(1):62-5. PubMed ID: 1148076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case.
    Wuis EW; Driessen JJ; Evers J; Vree TB; van der Kleyn E
    Eur J Anaesthesiol; 1986 May; 3(3):219-23. PubMed ID: 3780690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia. Considerations for the ophthalmologist.
    Sedwick LA; Romano PE
    Surv Ophthalmol; 1981; 25(6):378-82. PubMed ID: 7245023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
    Striebel HW; Lechner J; Wiegand C; Hartung E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia in a myopathic child. Prolonged postoperative course requiring dantrolene.
    Fletcher R; Blennow G; Olsson AK; Ranklev E; Törnebrandt K
    Acta Anaesthesiol Scand; 1982 Oct; 26(5):435-8. PubMed ID: 7148363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of malignant hyperthermia with dantrolene-sodium and uneventful re-anaesthesia after oral dantrolene-prophylaxis (author's transl)].
    Schulte-Sasse U; Tarnow J; Eberlein HJ
    Anaesthesist; 1982 May; 31(5):241-4. PubMed ID: 6896607
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant hyperthermia in a liver transplant patient: a case report.
    Fernandes CR; Azevedo DM; Gomes JM; Gonçalves BP; Coelho GR; Vasconcelos JB; Garcia JH
    Transplant Proc; 2007 Dec; 39(10):3530-2. PubMed ID: 18089429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overactivation of the sodium-calcium exchanger and transient receptor potential in anesthesia-induced malignant hyperthermia.
    Zhao P; Liu XM; Sun QC; Cui YF
    IUBMB Life; 2019 Dec; 71(12):2048-2054. PubMed ID: 31381266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dantrolene for malignant hyperthermia during anesthesia.
    Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-rigid type malignant hyperthermia and dantrolene sodium].
    Hayakawa A; Shimonaka H; Uematsu H; Yamamoto M
    Masui; 1988 Oct; 37(10):1243-8. PubMed ID: 3058994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.